Effectdossier · gearchiveerd kwartaal
CRVS
Corvus Pharmaceuticals, Inc. · Healthcare · Biotechnology
56Gevolgde houders
+2Δ houders
25.04MGehouden aandelen
$192.77MGerapporteerde waarde
+2Nieuwe posities
−0Uitstappen
Momentum-inputs (vergelijkbare managers):
breedte van houders +3.7% ·
aandelenstroom +14.5% ·
netto nieuwe posities +3.6%
· formule
Brede accumulatie: stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 68 | +6 | 34.72M | $518.70M | +11 | −5 |
| Q1 2026 | 64 | +8 | 30.80M | $450.00M | +15 | −7 |
| Q4 2025 | 56 | +2 | 25.04M | $192.77M | +2 | n/a |
| Q3 2025 | 14 | 0 | 18.71M | $137.91M | +2 | −2 |
| Q2 2025 | 11 | -1 | 17.31M | $69.23M | +1 | −2 |
| Q1 2025 | 9 | +2 | 6.14M | $19.53M | +2 | n/a |
| Q4 2024 | 7 | -1 | 4.46M | $23.85M | n/a | −1 |
| Q3 2024 | 7 | 0 | 7.32M | $38.63M | n/a | n/a |
| Q2 2024 | 7 | n/a | 7.37M | $13.41M | n/a | n/a |
Wie het bezit · Q4 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 5.06M | +7.3% | $38.93M | 0.0% | ▲ Add | 3 | SEC ↗ ×9 |
| 2 | The Vanguard Group ✦ (passief) | 3.87M | +11.6% | $29.83M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 3 | Morgan Stanley ✦ | 3.57M | +478.1% | $27.47M | 0.0% | ▲ Add | 2 | SEC ↗ ×6 |
| 4 | Point72 Asset Management ✦ | 2.88M | -55.5% | $22.14M | 0.0% | ▼ Trim | 7 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (passief) | 2.79M | +177.1% | $21.47M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passief) | 1.47M | +1.1% | $11.35M | 0.0% | ▲ Add | 7 | SEC ↗ ×2 |
| 7 | Millennium Management ✦ | 688.77K | Nieuw | $5.30M | 0.0% | New | 1 | SEC ↗ |
| 8 | Goldman Sachs Group ✦ | 553.33K | +24.2% | $4.26M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 9 | Northern Trust Corp | 429.77K | n/a | $3.31M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 10 | Barclays Plc | 394.77K | n/a | $3.04M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Jane Street Group, Llc | 378.30K | n/a | $2.91M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 12 | Wellington Management ✦ | 314.68K | +74.7% | $2.42M | 0.0% | ▲ Add | 4 | SEC ↗ ×3 |
| 13 | Bank Of America Corp /De/ | 236.50K | n/a | $1.82M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 14 | Marshall Wace ✦ | 216.25K | Nieuw | $1.67M | 0.0% | New | 1 | SEC ↗ ×2 |
| 15 | UBS Group AG | 212.01K | n/a | $1.63M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 16 | Citadel Advisors ✦ | 208.18K | +386.8% | $1.60M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Charles Schwab Investment… | 171.17K | n/a | $1.32M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 143.60K | -29.4% | $1.11M | 0.0% | ▼ Trim | 7 | SEC ↗ |
| 19 | Bank of New York Mellon Corp | 131.63K | n/a | $1.01M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 20 | Raymond James Financial Inc | 121.16K | n/a | $932,909 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 21 | Hsbc Holdings Plc | 118.54K | n/a | $902,074 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 22 | Qube Research & Technologies Ltd | 114.50K | n/a | $881,650 | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Squarepoint Ops LLC | 104.82K | n/a | $807,114 | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Rhumbline Advisers | 70.73K | n/a | $544,591 | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Nuveen, LLC | 68.06K | n/a | $524,093 | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Osaic Holdings, Inc. | 67.99K | n/a | $523,545 | 0.0% | n/c | 1 | SEC ↗ |
| 27 | D. E. Shaw & Co. ✦ | 64.92K | +153.8% | $499,846 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 28 | Wells Fargo & Company/Mn | 62.62K | n/a | $482,198 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 29 | Susquehanna International Group, Llp | 61.75K | n/a | $475,506 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 30 | Deutsche Bank Ag\ | 56.04K | n/a | $431,500 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 31 | Invesco Ltd. | 43.58K | n/a | $335,589 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 32 | Creative Planning | 39.18K | n/a | $301,671 | 0.0% | n/c | 1 | SEC ↗ |
| 33 | T. Rowe Price ✦ | 34.10K | +5.2% | $263,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 34 | MIRAE ASSET GLOBAL ETFS HOLDINGS… | 32.41K | n/a | $248,327 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 35 | JPMorgan Chase ✦ | 30.66K | -52.5% | $236,043 | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 36 | Connor, Clark & Lunn Investment… | 28.12K | n/a | $216,501 | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Voya Investment Management Llc | 27.66K | n/a | $212,990 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 38 | Group One Trading Llc | 26.67K | n/a | $205,336 | 0.0% | n/c | 1 | SEC ↗ |
| 39 | Balyasny Asset Management L.P. | 25.03K | n/a | $192,739 | 0.0% | n/c | 1 | SEC ↗ |
| 40 | New York State Common Retirement… | 18.80K | n/a | $144,760 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Manufacturers Life Insurance… | 17.50K | n/a | $134,727 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Alliancebernstein L.P. | 17.12K | n/a | $131,824 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Citigroup Inc | 14.86K | n/a | $114,407 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 44 | ProShare Advisors LLC | 13.76K | n/a | $105,983 | 0.0% | n/c | 1 | SEC ↗ |
| 45 | Captrust Financial Advisors | 11.05K | n/a | $85,093 | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Russell Investments Group, Ltd. | 6.66K | n/a | $51,290 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 47 | Bnp Paribas Financial Markets | 6.57K | n/a | $50,558 | 0.0% | n/c | 1 | SEC ↗ |
| 48 | Legal & General Group Plc | 5.79K | n/a | $44,560 | 0.0% | n/c | 1 | SEC ↗ |
| 49 | Mirae Asset Global Investments Co.… | 3.63K | n/a | $27,943 | 0.0% | n/c | 1 | SEC ↗ |
| 50 | California State Teachers… | 3.52K | n/a | $27,135 | 0.0% | n/c | 1 | SEC ↗ |
| 51 | Fidelity (FMR) ✦ | 2.29K | +55.6% | $17,643 | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 52 | Royal Bank Of Canada | 1.62K | n/a | $12,000 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 53 | UBS AM, a distinct business unit of… | 725 | n/a | $5,583 | 0.0% | n/c | 1 | SEC ↗ |
| 54 | Cwm, Llc | 205 | n/a | $2,000 | 0.0% | n/c | 1 | SEC ↗ |
| 55 | Daiwa Securities Group Inc. | 225 | n/a | $2,000 | 0.0% | n/c | 1 | SEC ↗ |
| 56 | Pnc Financial Services Group, Inc. | 137 | n/a | $1,055 | 0.0% | n/c | 1 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Millennium Management | $5.30M | 0.0% |
| Marshall Wace | $1.67M | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 163 houders, 69.83M aandelen, $976.09M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q4 2025 ·
Methodologie ·
Verkrijg dit via de API